Bassaganya-Riera Josep 13D and 13G filings for Landos Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:01 pm Sale |
2023-12-31 | 13G | Landos Biopharma, Inc. LABP |
Bassaganya-Riera Josep | 0 0.000% |
-572,087 (Position Closed) |
Filing |
| 2023-02-14 5:00 pm Sale |
2022-12-31 | 13G | Landos Biopharma, Inc. LABP |
Bassaganya-Riera Josep | 572,087 14.200% |
-65,000 (-10.20%) |
Filing |
| 2022-02-14 5:00 pm Purchase |
2021-12-31 | 13G | Landos Biopharma, Inc. LABP |
Bassaganya-Riera Josep | 637,087 15.800% |
637,087 (New Position) |
Filing |